Thus, we believe that FcγRIIb facilitates tau phosphorylation and neuronal loss in AD brains, consistent with the proposed role of tau in AD pathogenesis, such as severe memory impairment and neuronal loss (Ballatore et al., 2007). Here, MAPT is linked to Alzheimer disease.